Literature DB >> 22291099

Nosocomial transmission of norovirus is mainly caused by symptomatic cases.

Faizel H A Sukhrie1, Peter Teunis, Harry Vennema, Cedrick Copra, Matthias F C Thijs Beersma, Jolanda Bogerman, Marion Koopmans.   

Abstract

BACKGROUND: Nosocomial norovirus (NoV) infection is common and may increase the burden of disease in healthcare settings, particularly in vulnerable hospitalized patients. Implementing effective infection control during and after admission may limit further spread, but evidence-based measures are lacking.
METHODS: In this study, we performed a systematic evaluation of sources and modes of transmission during NoV outbreaks within 2 types of healthcare facilities. An outbreak protocol was developed to sample all patients and healthcare workers (HCWs) with and without symptoms on wards involved in outbreaks. Data on clinical history and possible high-risk exposures were collected. Five outbreaks were investigated, involving 28 patients with recognized symptomatic NoV infection.
RESULTS: Enhanced sampling, however, yielded 65 additional cases, of whom 14% (n = 9) were asymptomatic patients, 57% (n = 37) were symptomatic HCWs, and 17% (n = 11) were asymptomatic HCWs. For 12% (n = 8), clinical data were not provided (2 HCWs and 6 patients). On the basis of the shedding kinetics, the onset of infection was estimated for each case. The generation interval was then used to construct plausible transmission pathways and reproduction numbers for symptomatic and asymptomatic patients and HCWs.
CONCLUSIONS: We found that symptomatic patients and HCWs were more often involved in transmission events than asymptomatic shedders. Asymptomatic HCWs rarely contributed to transmission, despite high levels of fecal virus shedding.

Entities:  

Mesh:

Year:  2012        PMID: 22291099     DOI: 10.1093/cid/cir971

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  55 in total

1.  Environmental Surveillance for Noroviruses in Selected South African Wastewaters 2015-2016: Emergence of the Novel GII.17.

Authors:  V V Mabasa; K D Meno; M B Taylor; Janet Mans
Journal:  Food Environ Virol       Date:  2017-08-04       Impact factor: 2.778

Review 2.  Burden of norovirus in healthcare facilities and strategies for outbreak control.

Authors:  A Kambhampati; M Koopmans; B A Lopman
Journal:  J Hosp Infect       Date:  2015-02-04       Impact factor: 3.926

3.  Characteristics and outcomes of patients diagnosed with norovirus gastroenteritis after allogeneic hematopoietic stem cell transplantation based on immunochromatography.

Authors:  Ryosuke Ueda; Shigeo Fuji; Shin-ichiro Mori; Nobuhiro Hiramoto; Hisayoshi Hashimoto; Takashi Tanaka; Kohei Tada; Yujin Kobayashi; Noriyuki Morikawa; Akihito Shinohara; Keiji Okinaka; Akiko M Maeshima; Saiko Kurosawa; Sung-Won Kim; Takuya Yamashita; Takahiro Fukuda
Journal:  Int J Hematol       Date:  2015-05-01       Impact factor: 2.490

4.  Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in China.

Authors:  Tim K Tsang; Tian-Mu Chen; Ira M Longini; M Elizabeth Halloran; Ying Wu; Yang Yang
Journal:  Epidemiology       Date:  2018-09       Impact factor: 4.822

5.  Infectious disease transmission as a forensic problem: who infected whom?

Authors:  Peter Teunis; Janneke C M Heijne; Faizel Sukhrie; Jan van Eijkeren; Marion Koopmans; Mirjam Kretzschmar
Journal:  J R Soc Interface       Date:  2013-02-06       Impact factor: 4.118

6.  Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Authors:  Timothy J Nice; Megan T Baldridge; Broc T McCune; Jason M Norman; Helen M Lazear; Maxim Artyomov; Michael S Diamond; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

Review 7.  Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Authors:  Stuart S Kaufman; Kim Y Green; Brent E Korba
Journal:  Antiviral Res       Date:  2014-02-25       Impact factor: 5.970

Review 8.  Infection control for norovirus.

Authors:  L Barclay; G W Park; E Vega; A Hall; U Parashar; J Vinjé; B Lopman
Journal:  Clin Microbiol Infect       Date:  2014-07-16       Impact factor: 8.067

9.  Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options.

Authors:  Molly K Steele; Justin V Remais; Manoj Gambhir; John W Glasser; Andreas Handel; Umesh D Parashar; Benjamin A Lopman
Journal:  Epidemics       Date:  2016-10-24       Impact factor: 4.396

Review 10.  Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.

Authors:  Negar Aliabadi; Ben A Lopman; Umesh D Parashar; Aron J Hall
Journal:  Expert Rev Vaccines       Date:  2015-07-29       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.